Endometriosis Knowledgebase


A repository for genes associated with endometriosis

Results


PMID 25977120
Gene Name ST2
Condition Endometriosis
Association Associated
Population size 50
Population details 50 (30 women with laparoscopic and histopathological confirmed endometriosis, 20 control women without pelvic pathology)
Sex Female
Associated genes ST2, IL-33
Other associated phenotypes Endometriosis
Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population.

Immunol Lett. 2015 Jul;166(1):1-5. doi: 10.1016/j.imlet.2015.05.002. Epub 2015

Mbarik, Maroua| Kaabachi, Wajih| Henidi, Balkis| Sassi, Faycal Haj| Hamzaoui, Kamel

Tunis El Manar University, Medicine Faculty of Tunis, Department of Immunology and Histology, Tunisia. Electronic address: marwambarik@gmail.com.| Tunis El Manar University, Medicine Faculty of Tunis, Department of Immunology and Histology, Tunisia; A.

Interleukin-33 is an IL-1 family cytokine which signals via its T1/ST2 receptor, and acts as a key regulator of inflammation. This study aims to measure the expression of soluble ST2 (sST2) and IL-33 in endometriosis. We investigated thirty women with laparoscopic and histopathological confirmed endometriosis and 20 control women without pelvic pathology. Peripheral blood mononuclear cells and peritoneal fluid (PF) were assessed for sST2 and IL-33 levels that are measured by sandwich enzyme-linked immunosorbent assay. Peritoneal fluid IL-33 mRNA expression was quantified by real-time reverse transcription polymerase chain reaction assays. We found that IL-33 levels in PF and in serum were significantly higher in patients with endometriosis compared to women without endometriosis (P < 0.05). IL-33 increased levels were significantly more important in PF [10.45 +/- 14.33 ng/mL] than in serum [2.68 +/- 1.54 ng/mL] from endometriosis patients. Higher levels of IL-33 mRNA expression were detected in PF from patients with endometriosis. Soluble ST2 levels in PF were significantly different between patients [2.96 +/- 0.98 ng/mL; P < 0.0001] and controls [0.88 +/- 0.076 ng/mL]. Serum sST2 levels were similarly expressed in endometriosis patients and in controls (P > 0.05). Significant correlation was observed between IL-33 and sST2 levels in PF. In conclusion, IL-33 and sST2 values observed in PF were found to correlate with endometriosis severity. Elevated and correlated PF IL-33 and sST2 levels from patients with endometriosis suggested a potential role as surrogate markers of disease activity.

Mesh Terms: Ascitic Fluid/*metabolism| Biomarkers/blood/metabolism| Endometriosis/diagnosis/genetics/*pathology| Enzyme-Linked Immunosorbent Assay| Female| Humans| Inflammation| Interleukin-1 Receptor-Like 1 Protein| Interleukin-33/blood/genetics/*metabolism|